Frequency of long-term nonprogressors in HIV-1 seroconverters from rakai uganda

Journal of Acquired Immune Deficiency Syndromes

Volumn 52, Issue 3, 2009, Pages 316-319

  Laeyendecker, Oliver ^a,b   Redd, Andrew D ^a   Lutalo, Tom ^c   Gray, Ronald H ^d   Wawer, Maria ^d   Ssempijja, Victor ^d   Gamiel, Jordyn ^b   Bwanika, John Baptist ^c   Makumbi, Fred ^c,e   Nalugoda, Fred ^c   Opendi, Pius ^c   Kigozi, Godfrey ^c   Ndyanabo, Anthony ^c   Iga, Boaz ^c   Kiwanuka, Noah ^c,e   Sewankambo, Nelson ^e   Reynolds, Steven J ^a,b   Serwadda, David ^e   Quinn, Thomas C ^a,b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c RAKAI HEALTH SCIENCES PROGRAM   (Uganda)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e MAKERERE UNIVERSITY   (Uganda)

Author keywords

Africa; HIV; HIV disease progression; Long term nonprogressors

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LONG TERM NONPROGRESSOR; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RURAL AREA; SEROCONVERSION; SURVIVAL RATE; UGANDA; VIRUS LOAD;

ADULT; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; TIME FACTORS; UGANDA; YOUNG ADULT;

EID: 70350548088     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181bc08f5     Document Type: Article

References (24)

1. UNAIDS. AIDS Epidemic Update. Geneva, Switzerland; 2007.
2. Deeks SG, Walker BD. Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity. 2007;27:406-416.
3. Baltimore D. Lessons from people with nonprogressive HIV infection. N Engl J Med. 1995;332:259-260.
4. Pantaleo G, Menzo S, Vaccarezza M, et al. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N Engl J Med. 1995;332:209-216.
5. Buchbinder SP, Katz MH, Hessol NA, et al. Long-term HIV-1 infection without immunologic progression. AIDS. 1994;8:1123-1128.
6. Kirchhoff F, Greenough TC, Brettler DB, et al. Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med. 1995;332:228-232.
7. Tang J, Rivers C, Karita E, et al. Allelic variants of human beta-chemokine receptor 5 (CCR5) promoter: evolutionary relationships and predictable associations with HIV-1 disease progression. Genes Immun. 1999;1: 20-27.
8. Anzala AO, Ball TB, Rostron T, et al. CCR2-64I allele and genotype association with delayed AIDS progression in African women. University of Nairobi Collaboration for HIV Research. Lancet. 1998;351: 1632-1633.
9. Pereyra F, Addo MM, Kaufmann DE, et al. Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. J Infect Dis. 2008;197:563-571.
10. Chakraborty R, Morel AS, Sutton JK, et al. Correlates of delayed disease progression in HIV-1-infected Kenyan children. J Immunol. 2005;174: 8191-8199.
11. Dolan MJ, Kulkarni H, Camargo JF, et al. CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms. Nat Immunol. 2007;8:1324-1336.
12. Emu B, Sinclair E, Favre D, et al. Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment. J Virol. 2005;79:14169-14178.
13. Addo MM, Draenert R, Rathod A, et al. Fully differentiated HIV-1 specific CD8+ Teffector cells are more frequently detectable in controlled than in progressive HIV-1 infection. PLoS One. 2007;2:e321.
14. Emu B, Sinclair E, Hatano H, et al. HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control. J Virol. 2008;82:5398-5407.
15. Kiwanuka N, Laeyendecker O, Robb M, et al. Effect of human immunodeficiency virus type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection. J Infect Dis. 2008;197:707-713.
16. Kanki PJ, Hamel DJ, Sankale JL, et al. Human immunodeficiency virus type 1 subtypes differ in disease progression. J Infect Dis. 1999;179: 68-73.
17. Vasan A, Renjifo B, Hertzmark E, et al. Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype. Clin Infect Dis. 2006;42:843-852.
18. Lutalo T, Gray RH, Wawer M, et al. Survival of HIV-infected treatment-naive individuals with documented dates of seroconversion in Rakai, Uganda. AIDS. 2007;21(Suppl 6):S15-S19.
19. Wawer MJ, Gray RH, Sewankambo NK, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis. 2005;191:1403-1409.
20. Koblin BA, van Benthem BH, Buchbinder SP, et al. Long-term survival after infection with human immunodeficiency virus type 1 (HIV-1) among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1995. Am J Epidemiol. 1999;150: 1026-1030.
21. Bussmann H, Wester CW, Masupu KV, et al. Low CD4+ T-lymphocyte values in human immunodeficiency virus-negative adults in Botswana. Clin Diagn Lab Immunol. 2004;11:930-935.
22. Madec Y, Boufassa F, Porter K, et al. Spontaneous control of viral load and CD4 cell count progression among HIV-1 seroconverters. AIDS. 2005;19:2001-2007.
23. Ashton LJ, Carr A, Cunningham PH, et al. Predictors of progression in long-term nonprogressors. Australian Long-Term Nonprogressor Study Group. AIDS Res Hum Retroviruses. 1998;14:117-121.
24. Giorgi JV, Hultin LE, McKeating JA, et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis. 1999;179:859-870.